Literature DB >> 25246639

Profound reduction in hospital admissions and musculoskeletal surgical procedures for rheumatoid arthritis with concurrent changes in clinical practice (1995-2010).

Len Harty1, Gary O'Toole2, Oliver FitzGerald2.   

Abstract

OBJECTIVES: The aims of this study were to audit the annual national incidence of inpatient days and musculoskeletal surgical procedures (MSKSPs) for RA patients and to establish concurrent changes in clinical rheumatology practice from 1995 to 2010.
METHODS: Hospital inpatient enquiry systems were evaluated for 57 hospitals from 1995 to 2010. National annual TNF inhibitor (TNFi) and MTX prescriptions were analysed. Trends were analysed by logistic regression and correlations by Spearman's rho.
RESULTS: Fifty-four thousand eight hundred and six RA inpatient records were reviewed from 1995 to 2010 [70% female, mean age 66 years (s.d. 16)]. RA inpatient days decreased from 53 671 in 1995 to 29 000 in 2010 (r(2) = 0.8, P < 0.0001). Inpatient MSKSPs for RA patients decreased from a peak of 370 in 1996 to 188 in 2010 (r(2) = 0.7, P < 0.0001). Knee and hip replacements for the general population annually increased over the past 15 years, yet there was a significant decrease in the annual ratio of hip arthroplasties and knee arthroplasties for RA patients compared with those done for the general population from 1995 to 2010 (r(2) = 0.6, P < 0.001 and r(2) = 0.8, P < 0.01, respectively). Annual national TNFi prescriptions increased from 2389 units in 2000 to 116 747 in 2010. Concurrently MTX prescriptions increased nationally from 3300 in 2001 to 9600 in 2010. During the same period there was an increase in rheumatologists from 15 to 40 and in orthopaedic surgeons from 64 to 88.
CONCLUSION: Elective MSKSPs for RA patients have almost halved over the past 15 years, despite an increase in hip and knee arthroplasties for the general population, along with an almost halving of inpatient days for RA patients.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  MTX; TNFi; co-morbidities; hip; knee; orthopaedics; outcomes; rheumatoid arthritis; surgery

Mesh:

Substances:

Year:  2014        PMID: 25246639     DOI: 10.1093/rheumatology/keu340

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  8 in total

1.  Trends in Gout and Rheumatoid Arthritis Hospitalizations in Canada From 2000 to 2011.

Authors:  Sharan K Rai; J Antonio Aviña-Zubieta; Natalie McCormick; Mary A De Vera; Diane Lacaille; Eric C Sayre; Hyon K Choi
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-05       Impact factor: 4.794

2.  Improved survival in rheumatoid arthritis: a general population-based cohort study.

Authors:  Yuqing Zhang; Na Lu; Christine Peloquin; Maureen Dubreuil; Tuhina Neogi; J Antonio Aviña-Zubieta; Sharan K Rai; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2016-06-23       Impact factor: 19.103

3.  Orthopedic Surgery Among Patients With Rheumatoid Arthritis: A Population-Based Study to Identify Risk Factors, Sex Differences, and Time Trends.

Authors:  Michael D Richter; Cynthia S Crowson; Eric L Matteson; Ashima Makol
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-09-07       Impact factor: 4.794

4.  Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry.

Authors:  Dimitrios A Pappas; Joel M Kremer; Jenny Griffith; George Reed; Bob Salim; Chitra Karki; Vishvas Garg
Journal:  Rheumatol Ther       Date:  2017-08-24

5.  Patterns of health care utilization of gout patients in Hawai'i-high rates of emergency department utilization as compared to rheumatoid arthritis.

Authors:  Victoria P Mak; Andrea M Siu; So Yung Choi; Hyeong Jun Ahn; Sian Yik Lim
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

6.  Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis.

Authors:  Samuel Hawley; René Cordtz; Lene Dreyer; Christopher J Edwards; Nigel K Arden; Antonella Delmestri; Alan Silman; Cyrus Cooper; Andrew Judge; Daniel Prieto-Alhambra
Journal:  Semin Arthritis Rheum       Date:  2017-09-23       Impact factor: 5.532

7.  Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to 2014.

Authors:  Edward Burn; Christopher J Edwards; David W Murray; Alan Silman; Cyrus Cooper; Nigel K Arden; Rafael Pinedo-Villanueva; Daniel Prieto-Alhambra
Journal:  BMJ Open       Date:  2018-01-27       Impact factor: 2.692

8.  Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data.

Authors:  Samuel Hawley; M Sanni Ali; René Cordtz; Lene Dreyer; Christopher J Edwards; Nigel K Arden; Cyrus Cooper; Andrew Judge; Kimme Hyrich; Daniel Prieto-Alhambra
Journal:  Rheumatology (Oxford)       Date:  2019-07-01       Impact factor: 7.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.